CGRWX
Price
$32.87
Change
+$0.15 (+0.46%)
Updated
Jun 26 closing price
Net Assets
756.29M
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

CGRWX vs RMEBX

Header iconCGRWX vs RMEBX Comparison
Open Charts CGRWX vs RMEBXBanner chart's image
Invesco Comstock Select A
Price$32.87
Change+$0.15 (+0.46%)
VolumeN/A
Net Assets756.29M
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
CGRWX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CGRWX vs. RMEBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRWX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. CGRWX (756M). CGRWX pays higher dividends than RMEBX: CGRWX (1.63) vs RMEBX (1.16). CGRWX was incepted earlier than RMEBX: CGRWX (40 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than CGRWX (0.93). CGRWX is a more actively managed with annual turnover of: 104.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than CGRWX: RMEBX (250) vs CGRWX (1000). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. CGRWX (-3.10). CGRWX (63.25) and RMEBX (62.71) have equivalent 5 years return.
CGRWXRMEBXCGRWX / RMEBX
Total Expense Ratio0.921.0786%
Annual Report Gross Expense Ratio0.931.0787%
Fund Existence40 years11 years-
Gain YTD5.8937.31581%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets756M106B1%
Annual Yield % from dividends1.631.16141%
Returns for 1 year-3.109.50-33%
Returns for 3 years4.0725.8816%
Returns for 5 years63.2562.71101%
Returns for 10 years17.0974.5123%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp